Stay updated on Pembrolizumab for ALL MRD Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.

Latest updates to the Pembrolizumab for ALL MRD Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe revision label was updated from v3.5.3 to v3.5.4, indicating a deployment or maintenance update to the site. There is no visible change to study content or user-facing features on this page.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page’s footer revision/version has been updated from v3.5.2 to v3.5.3, reflecting a site/platform release rather than any change to the clinical trial details.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded 'Acute lymphoid leukemia' as a condition term and added a 'Genetic and Rare Diseases Information Center' resource in the Resources section.SummaryDifference0.2%

- Check67 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a maintenance/version bump with no visible changes to study details.SummaryDifference0.1%

- Check75 days agoChange DetectedUpdated site revision from v3.4.2 to v3.4.3; the previous revision tag has been removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for ALL MRD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.